Therefore, we investigated the relationship between TOP2A expression and immune infiltration in NSCLC using Tumor IMmune Estimation Resource (TIMER), which allows systematic analysis of immune infiltrates across diverse cancer types (https://cistrome.shinyapps.io/timer/). This evidence concerns the gene TOP2A and neoplasm.